30%+ CAGR growth target
Management reiterated a 30%+ CAGR growth target, aiming for main board listing within three years.
Aakaar Medical Technologies · forward-looking guidance across the available source record.
Guidance tracker
Management reiterated a 30%+ CAGR growth target, aiming for main board listing within three years.
Target to onboard 50 clinics under the Zelix partner clinic platform by end of FY27, with minimum monthly business of ₹3-4 lakh per clinic.
Target to reduce debtor days to 110-100 in the coming year through distributor model shift and tighter credit controls.
Management aims to maintain gross margins at 60% post-distributor realization, not diluting margins despite model shift.